> bibliography

Initial Testing

     Burke, M.T., Gralla, R., Kris, M., Howard, J., & Monras, P.  (1985).  Subjective evaluation in non-small cell lung cancer:  Comparison of Karnofsky performance status with a patient generated visual analogue scale measuring activity. Proceedings of the IVth World Conference on Lung Cancer, 4, 42.

     Monras, P., Gralla, R.J., Burke, M.T., Kris, M.G., Howard, J., Niedzwiecki, D., & Folman, R.  (1985). Development of specific instruments for subjective evaluation of patients with lung cancer:  Comparison of observer assessment with patient generated visual analogue scales (VAS).  Proceedings of the American Society of Clinical Oncology, 4, 251.

Conceptual Model
      Hollen, P.J., Gralla, R.J., Kris, M.G., & Cox, C.  (1994).  Quality of life during clinical trials:  Conceptual model for the Lung Cancer Symptom Scale (LCSS). Supportive Care in Cancer, 2,  213-222.

Extended Testing
      Hollen, P.J., Gralla, R.J., Kris, M.G., & Potanovich, L.M.  (1993).  Quality of life assessment in individuals with lung cancer:  Testing the Lung Cancer Symptom Scale (LCSS).  European Journal of Cancer, 29A, S51-S58.

      Hollen, P.J., Gralla, R.J., Kris, M.G., Cox, C., Belani, C.P., Grunberg, S.M., Crawford, J., & Neidhart, J.A.  (1994).  Measurement of quality of life in patients with lung cancer in multicenter trials of new therapies:  Psychometric assessment of the Lung Cancer Symptom Scale.  Cancer, 73, 2087-2098.

Analysis Methods
      Hollen, P.J., Gralla, R.J., Cox, C., & Eberly, S.W.  (1994).  A dilemma in analysis: Measurement issues in the longitudinal analysis of quality of life in 673 patients with advanced lung cancer.  Proceedings of the American Society of Clinical Oncology, 13, 329.

     Hollen, P.J., Gralla, R.J., Cox, C., Eberly, S.W., & Kris, M.G.  (1997).  A dilemma in analysis:  Issues in the serial measurement of quality of life in patients with advanced lung cancer.  Lung Cancer, 18, 119-136.

     Hollen, P.J., Gralla, R.J., Rittenberg, C.N., Marques, C.B., & Silverman, C.R.  (1999).  Quality of life as a clinical trial endpoint:  Developing a method to determine an appropriate interval for serial assessment.  5th National Conference on Cancer Nursing Research, Amercian Cancer Society, & Association of Pediatric Oncology Nurses.  Newport Beach, CA, February 11-13, 1999.

     Gralla, R.J., Rittenberg, C.N., Hollen, P.J., Silverman, C.R., & Marques, C.B.  (1999).  How frequently should quality of life measures be repeated in patients receiving chemotherapy for non-small cell lung cancer:  Results of a prospective evaluation.  Proceedings of the 11th MASCC International Symposium.  Nice, France, February 18-20, 1999.

     Hollen, P.J., Gralla, R.J., & Kris, M.G.  (1995).  Lung Cancer Symptom Scale (LCSS): Administration, scoring, and procedures manual -- Version 1.1  (Available from first author).

Modifications
      Hollen, P.J., Gralla R.J., Liepa A.M., Symanowski, J.T., & Rusthoven, J.J. (2006). Measuring quality of life in patients with pleural mesothelioma using a modified version of the Lung Cancer Symptom Scale (LCSS): Psychometric properties of the LCSS-Meso. Supportive Care in Cancer, 14, 11-21.

      Hollen P.J., Gralla R.J., Liepa A.M., Symanowski, J.T., & Rusthoven, J.J. (2004). Adapting the Lung Cancer Symptom Scale (LCSS) to Mesothelioma: Using the LCSS-Meso conceptual model for validation. Cancer, 101(3), 587-597.

      Gralla, R.J., Hollen, P.J., Liepa, A.M., Symanowski, J.T., Rusthoven, J.J., Boyer, M.J., Jassem, J., Vogelzang, N.J. (2003). Documenting symptom palliation with chemotherapy using the LCSS-Meso: Results from the randomized trial of pemetrexed plus cisplatin vs. cisplatin alone in patients with malignant pleural mesothelioma. European Journal of Cancer, Suppl 1, S272.

      Gralla, R.J., Hollen, P.J., Liepa, A.M., Symanowski, J.T., Boyer, M.J., Jassem, J., Abraham, R., Rusthoven, J.R., & Vogelzang, N.J. (2003). Improving Quality of Life in Patients with Malignant Pleural Mesothelioma: Results of the Randomized Pemetrexed + Cisplatin vs Cisplatin Trial Using the LCSS-Meso Instrument. Proceedings of the American Society of Clinical Oncology, 22, 621 [abstr 2496].

      Gralla, R.J., Symanowski, J.T., Liepa, A.M., Boyer, M.J., Ruffie, P., Moro-Sibilot, D., Hollen, P.J. & Rusthoven, J.J. (2003). Can baseline quality of life parameters predict survival and other efficacy outcomes in malignant pleural mesothelioma?: Results from a 448-patient phase III trial. Lung Cancer, 41, S220.

Gralla, R.J., Hollen, P.J., Liepa, A.M., & Rusthoven, J.J (2001). Health-related quality of life of patients with malignant pleural mesothelioma treated with pemetrexed disodium. Eur J Cancer 2001; 37(6):282 [abstr 312].


Additional

     Hollen, P.J., Gralla, R.J. Kris, M.G., McCoy, S., & Moinpour, C.M. (2005). A comparison of visual analogue and numerical rating scale formats for the Lung Cancer Symptom Scale: Does format affect patient ratings of symptoms and quality of life? Quality of Life Research, 14, 837-848.

     Hollen, P.J., Gralla, R.J., & Rittenberg, C.N. (2004). Quality of life as a clinical trial endpoint: Determining the appropriate interval for repeated assessments in patients with advanced lung cancer. Supportive Care in Cancer, 12, 767-773.

     Hollen, P.J., & Gralla, R.J. (1996).  Comparison of instruments for measuring quality of life in patients with lung cancer.  Seminars in Oncology, 23, (Suppl5), 31-40.

_________________________________
* derived by LCSS